#1 Clinical Trials Search in Europe

Lenomorelin

Lenomorelin, also known as ghrelin, is a hormone primarily produced in the stomach that plays a crucial role in regulating appetite and energy balance. Recent clinical trials have been exploring its potential therapeutic applications in various medical conditions, including cancer-related weight loss, stroke recovery, alcohol dependence, and frailty in aging. This article summarizes the key findings from these trials and discusses the potential benefits and risks of using lenomorelin in medical treatments.

Table of Contents

What is LENOMORELIN (Ghrelin)?

LENOMORELIN, also known as Ghrelin, is a naturally occurring hormone primarily produced by the stomach[3]. It is often referred to as the “hunger hormone” because it plays a crucial role in regulating appetite and food intake[5]. Ghrelin was first discovered in 1999 and has since been the subject of extensive research due to its potential therapeutic applications[6].

Other names for this hormone include:

  • Acylated Ghrelin
  • Octanoyl Ghrelin
  • Human acetylated ghrelin

How LENOMORELIN Works

LENOMORELIN works by binding to specific receptors in the body, primarily in the brain and stomach. Its main functions include:

  • Stimulating appetite: Ghrelin acts on the brain’s hunger centers, increasing the desire to eat[1].
  • Promoting positive energy balance: It helps trigger a state where the body takes in more energy than it expends[6].
  • Stimulating growth hormone secretion: Ghrelin can increase the release of growth hormone from the pituitary gland[3].
  • Potential anti-inflammatory effects: Some research suggests ghrelin may have anti-inflammatory properties[6].

Potential Medical Uses

While LENOMORELIN is still primarily used in research settings, scientists are exploring its potential in treating various conditions:

  • Cancer-related cachexia: This is a condition of severe malnutrition and muscle wasting in advanced cancer patients. Ghrelin may help stimulate appetite and promote weight gain in these individuals[6].
  • Frailty in older adults: Researchers are investigating whether ghrelin can help improve food intake and physical function in frail elderly individuals[4].
  • Peripheral Artery Disease (PAD): Studies are exploring ghrelin’s potential to improve functioning in people with PAD, a condition that affects blood flow to the limbs[7].
  • Stroke recovery: Some research is looking into whether ghrelin could improve recovery and long-term outcomes in patients who have had a stroke[2].
  • Alcohol dependence: Interestingly, researchers are studying how ghrelin might affect alcohol cravings and could potentially be used in treating alcohol dependence[3].

How LENOMORELIN is Administered

In clinical trials, LENOMORELIN is typically administered in one of the following ways:

  • Subcutaneous injection: This involves injecting the medication just under the skin[4].
  • Intravenous injection: The medication is injected directly into a vein[8].

The dosage and frequency of administration can vary widely depending on the specific study and condition being treated. It’s important to note that outside of clinical trials, ghrelin is not currently approved for general medical use.

Ongoing Research and Clinical Trials

Several clinical trials are currently underway to better understand the potential benefits and risks of LENOMORELIN:

  • A study investigating ghrelin’s effects on decision-making related to food choices and financial decisions[5].
  • Research on ghrelin’s potential to improve appetite and nutritional status in cancer patients experiencing weight loss[1].
  • A trial exploring whether ghrelin can enhance recovery in stroke patients[2].
  • Studies on the use of ghrelin in frail elderly individuals to improve food intake and physical function[4].

Potential Side Effects and Safety

As LENOMORELIN is still primarily used in research settings, its full side effect profile is not yet fully understood. However, some potential effects observed in clinical trials include:

  • Changes in blood sugar levels: Ghrelin may affect glucose metabolism[2].
  • Changes in blood pressure: Some studies monitor blood pressure closely after ghrelin administration[2].
  • Effects on the cardiovascular system: Ghrelin may influence heart rate and blood flow[8].

It’s crucial to note that the safety and efficacy of LENOMORELIN are still being studied, and it should only be used under close medical supervision in the context of approved clinical trials.

Condition Study Focus Administration Method Key Findings/Potential Benefits
Cancer-related weight loss Improving appetite and nutritional status Daily subcutaneous injection Potential to improve appetite in weight-losing cancer patients
Stroke recovery Enhancing functional outcomes Intravenous infusion May improve early recovery and long-term functional outcome in stroke patients
Alcohol dependence Effects on alcohol cue reactivity and craving Single intravenous injection Investigating impact on alcohol craving and cue-reactivity responses
Frailty in aging Improving food intake and physical function Daily subcutaneous injection Potential to sustainably increase caloric intake in frail older people
Peripheral Artery Disease (PAD) Improving functioning and vascular health Subcutaneous injection Investigating effects on circulating levels and vascular function

FAQ

  • What is lenomorelin (ghrelin) and how does it work? Lenomorelin, also known as ghrelin, is a hormone produced mainly in the stomach. It stimulates appetite and food intake by acting on the brain's hunger centers. In clinical trials, it's being studied for its potential to improve appetite, weight gain, and other health outcomes in various medical conditions.
  • What medical conditions are being studied with lenomorelin? Clinical trials are exploring the use of lenomorelin in several conditions, including cancer-related weight loss, stroke recovery, alcohol dependence, frailty in aging, and peripheral artery disease. Researchers are investigating its potential to improve appetite, physical function, and overall health outcomes in these conditions.
  • How is lenomorelin administered in clinical trials? In the trials described, lenomorelin is typically administered through injections. These can be subcutaneous (under the skin) or intravenous (into a vein). The dosage and frequency of administration vary depending on the specific study and condition being treated.
  • Are there any side effects or risks associated with lenomorelin treatment? While the studies are still ongoing, researchers are carefully monitoring for any adverse events. Some trials specifically look at safety and tolerability as primary outcomes. As with any medical treatment, there may be potential risks or side effects, which is why careful monitoring and follow-up are important parts of these clinical trials.
  • How might lenomorelin benefit patients in the future? If proven effective and safe, lenomorelin could potentially help patients with conditions like cancer-related weight loss by improving appetite and nutritional status. In stroke patients, it might aid recovery and improve functional outcomes. For alcohol dependence, it could help manage cravings. In frail elderly individuals, it might improve food intake and physical function. However, more research is needed to confirm these potential benefits.

Ongoing Clinical Trials on Lenomorelin

  • Study on the Effects of Lenomorelin in Patients with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy

    Recruiting

    2 1 1
    Investigated drugs:
    The Netherlands

  • Study of Ghrelin’s Effects on Decision-Making and Gambling Behavior in Healthy Adults: Comparison with Placebo

    Not recruiting

    2 1 1
    Investigated drugs:
    Sweden

Glossary

  • Lenomorelin: Also known as ghrelin, it's a hormone primarily produced in the stomach that stimulates appetite and food intake. It's being studied in clinical trials for various medical applications.
  • Ghrelin: Another name for lenomorelin, often referred to as the 'hunger hormone' due to its role in stimulating appetite.
  • Subcutaneous injection: A method of administering medication by injecting it into the layer of tissue just beneath the skin.
  • Intravenous (IV) injection: A method of administering medication directly into a vein.
  • Cue-reactivity: In the context of alcohol dependence studies, this refers to a person's response to stimuli (cues) associated with alcohol use.
  • Endovascular thrombectomy: A minimally invasive procedure used to remove a blood clot from a blood vessel in the brain in stroke patients.
  • Frailty: A medical syndrome in older adults characterized by decreased strength, endurance, and physiological function, increasing vulnerability to adverse health outcomes.
  • Sarcopenia: The loss of skeletal muscle mass and strength as a result of aging.
  • Peripheral Artery Disease (PAD): A circulatory condition in which narrowed arteries reduce blood flow to the limbs, often causing leg pain when walking.
  • Flow-mediated dilation (FMD): A non-invasive method to assess endothelial function and overall vascular health.

References

  1. https://clinicaltrials.gov/study/NCT00681486
  2. https://clinicaltrials.eu/trial/study-on-the-effects-of-lenomorelin-in-patients-with-acute-ischemic-stroke-undergoing-endovascular-thrombectomy/
  3. https://clinicaltrials.gov/study/NCT01190085
  4. https://clinicaltrials.gov/study/NCT01833078
  5. https://clinicaltrials.gov/study/NCT03198143
  6. https://clinicaltrials.gov/study/NCT00933361
  7. https://clinicaltrials.gov/study/NCT03358355
  8. https://clinicaltrials.gov/study/NCT00912587